Arvind Sood | Vice President of Investor Relations |
Robert Bradway | Chairman and Chief Executive Officer |
David Reese | Executive Vice President of Research and Development |
Murdo Gordon | Executive Vice President of Global Commercial Operations |
Peter Griffith | Executive Vice President and Chief Financial Officer |
Michael Yee | Jefferies & Company |
Matthew Harrison | Morgan Stanley |
Yaron Werber | Cowen & Company |
Jay Olson | Oppenheimer & Co. Inc. |
Terence Flynn | Goldman Sachs Group, Inc. |
Evan Seigerman | Credit Suisse |
Christopher Raymond | Piper Sandler & Co. |
Andrew Berens | SVB Leerink LLC |
Ronny Gal | Sanford C. Bernstein & Co., LLC |
Colin Bristow | UBS |
Mohit Bansal | Citigroup Inc. |
Geoffrey Meacham | Bank of America Merrill Lynch |
Kennen MacKay | RBC Capital Markets |
Umer Raffat | Evercore ISI |
Alethia Young | Cantor Fitzgerald & Co. |
Cory Kasimov | JPMorgan Chase & Co. |
Robyn Karnauskas | Truist Securities, Inc. |
My name is April, and I will be your conference facilitator today for Amgen's Third Quarter 2020 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the last speakers prepared remarks. [Operator Instructions] I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr.